J Shimazaki Selected Research

Inflammation (Inflammations)

10/2008	Alterations of the ocular surface epithelial MUC16 and goblet cell MUC5AC in patients with atopic keratoconjunctivitis.
2/2008	Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease.
12/2006	Alterations of the ocular surface epithelial mucins 1, 2, 4 and the tear functions in patients with atopic keratoconjunctivitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J Shimazaki Research Topics

Disease

4	Prostatic Neoplasms (Prostate Cancer) 05/2014 - 01/2000
4	Dry Eye Syndromes (Dry Eye Syndrome) 01/2009 - 11/2001
4	Neoplasms (Cancer) 08/2001 - 01/2000
3	Inflammation (Inflammations) 10/2008 - 12/2006
3	Neoplasm Metastasis (Metastasis) 08/2001 - 01/2000
2	Keratoconjunctivitis 02/2009 - 12/2006
2	Benign Mucous Membrane Pemphigoid (Cicatricial Pemphigoid) 01/2009 - 01/2007
1	Acanthamoeba Keratitis 04/2012
1	Stevens-Johnson Syndrome (Lyell's Syndrome) 05/2009
1	Corneal Perforation 02/2009
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2009
1	Bronchiolitis Obliterans Syndrome 02/2008
1	Burns 01/2005
1	Adenocarcinoma 08/2001
1	Chemical Burns (Chemical Burn) 03/2001
1	Ulcer 03/2001
1	Rheumatoid Arthritis 03/2001
1	Corneal Ulcer 03/2001
1	Stomach Neoplasms (Stomach Cancer) 01/2001
1	Hepatocellular Carcinoma (Hepatoma) 01/2001
1	Meibomitis 09/2000
1	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 09/2000
1	Blister (Bulla) 07/2000
1	Choroidal Effusions 07/2000
1	Glaucoma 07/2000
1	Pterygium 05/2000
1	Carcinoma in Situ 05/2000
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 03/2000
1	Prostatic Diseases 03/2000
1	Tics (Tic) 03/2000
1	Liver Diseases (Liver Disease) 01/2000
1	Hyperplasia 01/2000
1	Uterine Diseases (Endometrial Disease) 01/2000
1	Breast Neoplasms (Breast Cancer) 01/2000
1	Endometrial Neoplasms (Endometrial Cancer) 01/2000

Drug/Important Bio-Agent (IBA)

3	Messenger RNA (mRNA)IBA 10/2008 - 12/2006
3	Estrogens (Estrogen)FDA Link 10/2000 - 01/2000
3	Proteins (Proteins, Gene)FDA Link 05/2000 - 01/2000
2	Intravenous Immunoglobulins (IVIG)FDA Link 01/2009 - 01/2007
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 02/2008 - 09/2000
2	Prostate-Specific Antigen (Semenogelase)IBA 08/2001 - 03/2000
2	Estrogen Receptor alphaIBA 01/2000 - 01/2000
1	chlorhexidine gluconate (Dyna-Hex)FDA LinkGeneric 04/2012
1	Stainless Steel (Steel, Stainless)IBA 05/2009
1	LipidsIBA 01/2009
1	MucinsIBA 12/2006
1	AlbuminsIBA 10/2003
1	Ophthalmic Solutions (Eye Drops)IBA 11/2001
1	Glial Fibrillary Acidic ProteinIBA 01/2001
1	Periodic AcidIBA 01/2001
1	CAM 5.2 antigenIBA 01/2001
1	S100 Proteins (S 100 Protein)IBA 01/2001
1	Progesterone Receptors (Progesterone Receptor)IBA 10/2000
1	Hormones (Hormone)IBA 10/2000
1	Cromolyn Sodium (Cromoglicic Acid)FDA LinkGeneric 09/2000
1	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2000
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 07/2000
1	Telomerase (Telomerase Reverse Transcriptase)IBA 05/2000
1	Tumor Biomarkers (Tumor Markers)IBA 01/2000
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2000
1	Flutamide (Eulexin)FDA LinkGeneric 01/2000
1	NucleotidesIBA 01/2000
1	DNA (Deoxyribonucleic Acid)IBA 01/2000
1	Chlormadinone Acetate (Chlormadinone)IBA 01/2000
1	AndrogensIBA 01/2000
1	Mitogen-Activated Protein KinasesIBA 01/2000

Therapy/Procedure

4	Transplantation 01/2009 - 03/2001
3	Therapeutics 08/2001 - 01/2000
2	Corneal Transplantation (Keratoplasty) 02/2009 - 07/2000
2	Penetrating Keratoplasty 02/2009 - 07/2000
1	Heavy Ion Radiotherapy 05/2014
1	Stem Cell Transplantation 01/2009
1	Lymph Node Excision (Lymph Node Dissection) 01/2001
1	Gastrectomy 01/2001
1	Aftercare (After-Treatment) 09/2000
1	Trabeculectomy (Trabeculoplasty) 07/2000
1	Castration 01/2000